Skip to main content
Kimberly (Hawthorne) Goodspeed, MD, Pediatrics, Dallas, TX

KimberlyDianne(Hawthorne)GoodspeedMD

Pediatrics Dallas, TX

Neurodevelopmental Disabilities

Physician

Overview of Dr. Goodspeed

Dr. Kimberly Goodspeed is a pediatrician in Dallas, TX and is affiliated with University of Texas Southwestern Medical Center. She received her medical degree from McGovern Medical School at UTHealth and has been in practice 5 years. She is one of 269 doctors at University of Texas Southwestern Medical Center who specialize in Pediatrics. She has more than 20 publications and over 500 citings.

Education & Training

  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterFellowship, Neurodevelopmental Disabilities, 2014 - 2018
  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterResidency, Pediatrics, 2012 - 2015
  • McGovern Medical School at UTHealth
    McGovern Medical School at UTHealthClass of 2012

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2017 - 2026
  • American Board of Pediatrics Pediatrics
  • American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
  • American Board of Psychiatry and Neurology Neurodevelopmental Disabilities

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Pitt-Hopkins Syndrome: A Unique Case Study  
    Veronica Bordes Edgar, Kimberly Goodspeed, Journal of the International Neuropsychological Society

Press Mentions

  • Repurposing Approved Drugs as Inhibitors of K v 7.1 and Na v 1.8 to Treat Pitt Hopkins Syndrome
    Repurposing Approved Drugs as Inhibitors of K v 7.1 and Na v 1.8 to Treat Pitt Hopkins SyndromeJuly 22nd, 2020
  • Bringing Everyone to the Table – Findings from the 2018 Phelan-McDermid Syndrome Foundation International Conference
    Bringing Everyone to the Table – Findings from the 2018 Phelan-McDermid Syndrome Foundation International ConferenceJune 16th, 2020
  • Neurogene Initiates Natural History Study of Aspartylglucosaminuria (AGU)
    Neurogene Initiates Natural History Study of Aspartylglucosaminuria (AGU)April 23rd, 2019
  • Join now to see all